Citations (41)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
C. GrÅNÄS, G. Nordvall & D. Larhammar. (1998) Mutagenesis of the Human 5-HT1B Receptor: Differences from the Closely Related 5-HT1A Receptor and the Role of Residue F331 in Signal Transduction. Journal of Receptors and Signal Transduction 18:4-6, pages 225-241.
Read now
Read now
Articles from other publishers (40)
Huihao Tang, Chuanjun Shu, Haidi Chen, Xiaojing Zhang, Zhuqing Zang & Cheng Deng. (2019) Constitutively active BRS3 is a genuinely orphan GPCR in placental mammals. PLOS Biology 17:3, pages e3000175.
Crossref
Crossref
David L NelsonLee A PhebusKirk W JohnsonDavid B WainscottMarlene L CohenDavid O CalligaroYao-Chang Xu. (2010)
Preclinical pharmacological profile of the selective 5-HT
1F
receptor agonist lasmiditan
. Cephalalgia 30:10, pages 1159-1169.
Crossref
Crossref
Andrew Holmes & Gregory J. Quirk. (2010) Pharmacological facilitation of fear extinction and the search for adjunct treatments for anxiety disorders - the case of yohimbine. Trends in Pharmacological Sciences 31:1, pages 2-7.
Crossref
Crossref
Matthew J. Fell, Kenneth W. Perry, Julie F. Falcone, Bryan G. Johnson, Vanessa N. Barth, Karen S. Rash, Virginia L. Lucaites, Penny G. Threlkeld, James A. Monn, David L. McKinzie, Gerard J. Marek, Kjell A. Svensson & David L. Nelson. (2009)
In Vitro and in Vivo Evidence for a Lack of Interaction with Dopamine D
2
Receptors by the Metabotropic Glutamate 2/3 Receptor Agonists 1
S
,2
S
,5
R
,6
S
-2-Aminobicyclo[3.1.0]hexane-2,6-bicaroxylate Monohydrate (LY354740) and (−)-2-Oxa-4-aminobicyclo[3.1.0] Hexane-4,6-dicarboxylic Acid (LY379268)
. Journal of Pharmacology and Experimental Therapeutics 331:3, pages 1126-1136.
Crossref
Crossref
David R Thomas, Christopher G Larminie, Helen R Lyons, Andrew Fosberry, Matthew J Hill & Philip D Hayes. (2004) Cloning and pharmacological characterisation of the guinea pig 5-ht5A receptor. European Journal of Pharmacology 494:2-3, pages 91-99.
Crossref
Crossref
Fengju Bai, Tinggui Yin, Edward M. Johnstone, Chen Su, Gabor Varga, Sheila P. Little & David L. Nelson. (2004) Molecular cloning and pharmacological characterization of the guinea pig 5-HT1E receptor. European Journal of Pharmacology 484:2-3, pages 127-139.
Crossref
Crossref
María J. Vázquez, Ana M. Roa, Fernando Reyes, Alfonso Vega, Alfonso Rivera-Sagredo, David R. Thomas, Emilio Díez & Juan A. Hueso-Rodríguez. (2003)
A Novel Ergot Alkaloid as a 5-HT
1A
Inhibitor Produced by
Dicyma
sp.
. Journal of Medicinal Chemistry 46:24, pages 5117-5120.
Crossref
Crossref
Adrian Newman-Tancredi. (2003) Differential ligand efficacy at h5-HT1A receptor-coupled G-protein subtypes: a commentary. International Congress Series 1249, pages 101-117.
Crossref
Crossref
David R Thomas, Sergio Melotto, Mario Massagrande, Andrew D Gribble, Phillip Jeffrey, Alexander J Stevens, Nigel J Deeks, Peter J Eddershaw, Susan H Fenwick, Graham Riley, Tania Stean, Claire M Scott, Matthew J Hill, Derek N Middlemiss, Jim J Hagan, Gary W Price & Ian T Forbes. (2003)
SB-656104-A, a novel selective 5-HT
7
receptor antagonist, modulates REM sleep in rats
. British Journal of Pharmacology 139:4, pages 705-714.
Crossref
Crossref
Robert A. Coleman & Kenneth L. Clark. (2003) Target validation using human tissue: from gene expression to function. TARGETS 2:2, pages 58-64.
Crossref
Crossref
Adrian Newman-Tancredi, Didier Cussac, Laetitia Marini, Manuelle Touzard & Mark J Millan. (2003)
h5-HT
1B
receptor-mediated constitutive G
α
i3
-protein activation in stably transfected Chinese hamster ovary cells: an antibody capture assay reveals protean efficacy of 5-HT
. British Journal of Pharmacology 138:6, pages 1077-1084.
Crossref
Crossref
Lawrence J. Alvarez, Helen C. Turner, Aldo C. Zamudio & Oscar A. Candia. (2001)
Serotonin-elicited inhibition of Cl
−
secretion in the rabbit conjunctival epithelium
. American Journal of Physiology-Cell Physiology 280:3, pages C581-C592.
Crossref
Crossref
Valérie Audinot, Adrian Newman-Tancredi & Mark J. Millan. (2001) Constitutive activity at serotonin 5-HT1D receptors: detection by homologous GTPγS versus [35S]-GTPγS binding isotherms. Neuropharmacology 40:1, pages 57-64.
Crossref
Crossref
Petrus J Pauwels. (2000) Diverse signalling by 5-hydroxytryptamine (5-HT) receptors. Biochemical Pharmacology 60:12, pages 1743-1750.
Crossref
Crossref
Pankaj Bhalla, Hari S Sharma, Thierry Wurch, Petrus J Pauwels & Pramod R Saxena. (2000)
Molecular cloning, sequence analysis and pharmacological properties of the porcine 5-HT
1D
receptor
. British Journal of Pharmacology 131:5, pages 949-957.
Crossref
Crossref
Elliott S. Klein, Jenny W. Wang, Berket Khalifa, Stacey A. Gavigan & Roshantha A.S. Chandraratna. (2000) Recruitment of Nuclear Receptor Corepressor and Coactivator to the Retinoic Acid Receptor by Retinoid Ligands. Journal of Biological Chemistry 275:25, pages 19401-19408.
Crossref
Crossref
Mark J. Millan, Adrian Newman-Tancredi, Val�rie Audinot, Didier Cussac, Fran�oise Lejeune, Jean-Paul Nicolas, Francis Cog�, Jean-Pierre Galizzi, Jean A. Boutin, Jean-Michel Rivet, Anne Dekeyne & Alain Gobert. (2000) Agonist and antagonist actions of yohimbine as compared to fluparoxan at ?2-adrenergic receptors (AR)s, serotonin (5-HT)1A, 5-HT1B, 5-HT1D and dopamine D2 and D3 receptors. Significance for the modulation of frontocortical monoaminergic transmission and depressive states. Synapse 35:2, pages 79-95.
Crossref
Crossref
Brian Henry, Susan H. Fox, David Peggs, Alan R. Crossman & Jonathan M. Brotchie. (1999) The ?2-adrenergic receptor antagonist idazoxan reduces dyskinesia and enhances anti-parkinsonian actions ofL-dopa in the MPTP-lesioned primate model of Parkinson's disease. Movement Disorders 14:5, pages 744-753.
Crossref
Crossref
Stefania Gessi, Franca Campi, Katia Varani & Pier Andrea Borea. (1999) ?2-Adrenergic agonist modulation of [35S]GTP?S binding to guanine-nucleotide-binding-proteins in human platelet membranes. Life Sciences 64:16, pages 1403-1413.
Crossref
Crossref
Denis Morin, Nathalie Cotte, Marie-Noëlle Balestre, Bernard Mouillac, Maurice Manning, Christophe Breton & Claude Barberis. (1998)
The D136A mutation of the V
2
vasopressin receptor induces a constitutive activity which permits discrimination between antagonists with partial agonist and inverse agonist activities
. FEBS Letters 441:3, pages 470-475.
Crossref
Crossref
J. Watson, S. Brough, M. C. Coldwell, T. Gager, M. Ho, A. J. Hunter, J. Jerman, D. N. Middlemiss, G. J. Riley & A. M. Brown. (2009)
Functional effects of the muscarinic receptor agonist, xanomeline, at 5‐HT
1
and 5‐HT
2
receptors
. British Journal of Pharmacology 125:7, pages 1413-1420.
Crossref
Crossref
J V Selkirk, C Scott, M Ho, M J Burton, J Watson, L M Gaster, L Collin, B J Jones, D N Middlemiss & G W Price. (2009)
SB‐224289–a novel selective (human) 5‐HT
1B
receptor antagonist with negative intrinsic activity
. British Journal of Pharmacology 125:1, pages 202-208.
Crossref
Crossref
Adrian Newman-Tancredi, Samantha Gavaudan, Caroline Conte, Christine Chaput, Manuelle Touzard, Laurence Verrièle, Valerie Audinot & Mark J Millan. (1998) Agonist and antagonist actions of antipsychotic agents at 5-HT1A receptors: a []GTPγS binding study. European Journal of Pharmacology 355:2-3, pages 245-256.
Crossref
Crossref
David R. Thomas, Susan A. Gittins, Lissa L. Collin, Derek N. Middlemiss, Graham Riley, Jim Hagan, Israel Gloger, Catherine E. Ellis, Ian T. Forbes & Anthony M. Brown. (2009)
Functional characterisation of the human cloned 5‐HT
7
receptor (long form); antagonist profile of SB‐258719
. British Journal of Pharmacology 124:6, pages 1300-1306.
Crossref
Crossref
David B Wainscott, Kirk W Johnson, Lee A Phebus, John M Schaus & David L Nelson. (1998) Human 5-HT1F receptor-stimulated []GTPγS binding: correlation with inhibition of guinea pig dural plasma protein extravasation. European Journal of Pharmacology 352:1, pages 117-124.
Crossref
Crossref
Richard H Alper & David L Nelson. (1998) Characterization of 5-HT1A receptor-mediated []GTPγS binding in rat hippocampal membranes. European Journal of Pharmacology 343:2-3, pages 303-312.
Crossref
Crossref
Petrus J Pauwels, Thierry Wurch, Christiane Palmier & Francis C Colpaert. (2009)
Pharmacological analysis of G‐protein activation mediated by guinea‐pig recombinant 5‐HT
1B
receptors in C6‐glial cells: similarities with the human 5‐HT
1B
receptor
. British Journal of Pharmacology 123:1, pages 51-62.
Crossref
Crossref
Masao Hiraiwa, W.Marie Campana, Brian M. Martin & John S. O'brien. (1997) Prosaposin Receptor: Evidence for a G-Protein-Associated Receptor. Biochemical and Biophysical Research Communications 240:2, pages 415-418.
Crossref
Crossref
Petrus J. Pauwels. (1997) receptor antagonists. General Pharmacology: The Vascular System 29:3, pages 293-303.
Crossref
Crossref
Colin Davidson, Michael Ho, Gary W. Price, Brian J. Jones & Jonathan A. Stamford. (2009)
(+)‐WAY 100135, a partial agonist, at native and recombinant 5‐HT
1B/1D
receptors
. British Journal of Pharmacology 121:4, pages 737-742.
Crossref
Crossref
C ROBERTS, G.W PRICE, L GASTER, B.J JONES, D.N MIDDLEMISS & C ROUTLEDGE. (1997) Importance of h5-HT 1B Receptor Selectivity for 5-HT Terminal Autoreceptor Activity: an In Vivo Microdialysis Study in the Freely-moving Guinea-pig. Neuropharmacology 36:4-5, pages 549-557.
Crossref
Crossref
P.J. PAUWELS, S. TARDIF, C. PALMIER, T. WURCH & F.C. COLPAERT. (1997) How Efficacious are 5-HT 1B/D Receptor Ligands: an Answer from GTPγS Binding Studies with Stably Transfected C6-glial Cell Lines. Neuropharmacology 36:4-5, pages 499-512.
Crossref
Crossref
Adrian Newman‐Tancredi, Caroline Conte, Christine Chaput, Michael Spedding & Mark J Millan. (2009)
Inhibition of the constitutive activity of human 5‐HT
1A
receptors by the inverse agonist, spiperone but not the neutral antagonist, WAY 100,635
. British Journal of Pharmacology 120:5, pages 737-739.
Crossref
Crossref
Josephine A Stanton & Margaret S Beer. (1997) Characterisation of a cloned human 5-HT1A receptor cell line using [35S]GTPγS binding. European Journal of Pharmacology 320:2-3, pages 267-275.
Crossref
Crossref
Katia Befort, Lina Tabbara & Brigitte L. Kieffer. (2013) [35S]GTPγS binding: A tool to evaluate functional activity of a cloned opioid receptor transiently expressed in COS cells. Neurochemical Research 21:11, pages 1301-1307.
Crossref
Crossref
Margaret R. MacLean, Robin A. Clayton, Alison G.B. Templeton & Ian Morecroft. (2012)
Evidence for 5‐HT
1
‐like receptor‐mediated vasoconstriction in human pulmonary artery
. British Journal of Pharmacology 119:2, pages 277-282.
Crossref
Crossref
Adrian Newman-Tancredi, Christine Chaput, Laurence Verrièle & Mark J. Millan. (1996) S 15535 and WAY 100,635 antagonise 5-HT-stimulated [35S]GTPγS binding at cloned human 5-HT1A receptors. European Journal of Pharmacology 307:1, pages 107-111.
Crossref
Crossref
Heather Giles, S.J. Lansdell, M.-L. Bolofo, H.L. Wilson & G.R. Martin. (1996) Characterization of a 5-HT1B receptor on CHO cells: functional responses in the absence of radioligand binding. British Journal of Pharmacology 117:6, pages 1119-1126.
Crossref
Crossref
Graeme Milligan. (1996) The stoichiometry of expression of protein components of the stimulatory adenylyl cyclase cascade and the regulation of information transfer. Cellular Signalling 8:2, pages 87-95.
Crossref
Crossref
G.W. Price, C. Roberts, J. Watson, M. Burton, K. Mulholland, D.N. Middlemiss & B.J. Jones. (1995) Species differences in 5-HT autoreceptors. Behavioural Brain Research 73:1-2, pages 79-82.
Crossref
Crossref